<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36471421</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1654</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Reviews in medical virology</Title><ISOAbbreviation>Rev Med Virol</ISOAbbreviation></Journal><ArticleTitle>Partners in crime: Autoantibodies complicit in COVID-19 pathogenesis.</ArticleTitle><Pagination><StartPage>e2412</StartPage><MedlinePgn>e2412</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2412</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/rmv.2412</ELocationID><Abstract><AbstractText>Autoantibodies (AABs) play a critical role in the pathogenesis of autoimmune diseases (AIDs) and serve as a diagnostic and prognostic tool in assessing these complex disorders. Viral infections have long been recognized as a principal environmental factor affecting the production of AABs and the development of autoimmunity. COVID-19 has primarily been considered a hyperinflammatory syndrome triggered by a cytokine storm. In the following, the role of maladaptive B cell response and AABs became more apparent in COVID-19 pathogenesis. The current review will primarily focus on the role of extrafollicular B cell response, Toll-like receptor-7 (TLR-7) activation, and neutrophil extracellular traps (NETs) formation in the development of AABs following SARS-CoV-2 infection. In the following, this review will clarify how these AABs dysregulate immune response to SARS-CoV-2 by disrupting cytokine function and triggering neutrophil hyper-reactivity. Finally, the pathologic effects of these AABs will be further described in COVID-19 associate clinical manifestations, including venous and arterial thrombosis, a multisystem inflammatory syndrome in children (MIS-C), acute respiratory distress syndrome (ARDS), and recently described post-acute sequelae of COVID-19 (PASC) or long-COVID.</AbstractText><CopyrightInformation>&#xa9; 2022 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taghadosi</LastName><ForeName>Mahdi</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3516-0130</Identifier><AffiliationInfo><Affiliation>Immunology Department, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Safarzadeh</LastName><ForeName>Elham</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Parasitology, and Immunology, Ardabil University of Medical Sciences, Ardabil, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asgarzadeh</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Students Research Committee, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roghani</LastName><ForeName>Seyed Askar</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shamsi</LastName><ForeName>Afsaneh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Immunology Department, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jalili</LastName><ForeName>Cyrus</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Kermanshah University of Medical Sciences, Kermanshah, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assar</LastName><ForeName>Shirin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soufivand</LastName><ForeName>Parviz</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pournazari</LastName><ForeName>Mehran</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feizollahi</LastName><ForeName>Parisa</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Immunology Department, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicknam</LastName><ForeName>Mohammad Hossein</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Immunology Research Centre, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asghariazar</LastName><ForeName>Vahid</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Deputy of Research and Technology, Ardabil University of Medical Sciences, Ardabil, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaziri</LastName><ForeName>Siavash</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Infectious Disease Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahriari</LastName><ForeName>Hossein</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Clinical Immunology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammadi</LastName><ForeName>Asadollah</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cellular and Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Rev Med Virol</MedlineTA><NlmUniqueID>9112448</NlmUniqueID><ISSNLinking>1052-9276</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000705967">pediatric multisystem inflammatory disease, COVID-19 related</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003415" MajorTopicYN="N">Crime</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">autoantibody (AAB)</Keyword><Keyword MajorTopicYN="N">autoimmunity</Keyword></KeywordList><CoiStatement>The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>6</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36471421</ArticleId><ArticleId IdType="pmc">PMC9877745</ArticleId><ArticleId IdType="doi">10.1002/rmv.2412</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Salle V. Coronavirus&#x2010;induced autoimmunity. Clin Immunol. 2021;226:108694. 10.1016/j.clim.2021.108694</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2021.108694</ArticleId><ArticleId IdType="pmc">PMC8005338</ArticleId><ArticleId IdType="pubmed">33610741</ArticleId></ArticleIdList></Reference><Reference><Citation>Amital H, Gershwin ME, Shoenfeld Y. Reshaping the mosaic of autoimmunity. Seminars Arthritis Rheumatism. 2006;35(6):341&#x2010;343. 10.1016/j.semarthrit.2005.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2005.09.002</ArticleId><ArticleId IdType="pubmed">16765709</ArticleId></ArticleIdList></Reference><Reference><Citation>Quaglia M, Merlotti G, De Andrea M, Borgogna C, Cantaluppi V. Viral infections and systemic lupus erythematosus: new players in an old story. Viruses. 2021;13(2):277. 10.3390/v13020277</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020277</ArticleId><ArticleId IdType="pmc">PMC7916951</ArticleId><ArticleId IdType="pubmed">33670195</ArticleId></ArticleIdList></Reference><Reference><Citation>Gugliesi F, Pasquero S, Griffante G, et&#xa0;al. Human cytomegalovirus and autoimmune diseases: where are we? Viruses. 2021;13(2):260. 10.3390/v13020260</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020260</ArticleId><ArticleId IdType="pmc">PMC7914970</ArticleId><ArticleId IdType="pubmed">33567734</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakhmola S, Upadhyay A, Jain K, Mishra A, Jha HC. Herpesviruses and the hidden links to Multiple Sclerosis neuropathology. J Neuroimmunol. 2021;358:577636. 10.1016/j.jneuroim.2021.577636</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2021.577636</ArticleId><ArticleId IdType="pubmed">34174587</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussein HM, Rahal EA. The role of viral infections in the development of autoimmune diseases. Crit Rev Microbiol. 2019;45(4):394&#x2010;412. 10.1080/1040841x.2019.1614904</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1040841x.2019.1614904</ArticleId><ArticleId IdType="pubmed">31145640</ArticleId></ArticleIdList></Reference><Reference><Citation>Theofilopoulos AN, Kono DH, Baccala R. The multiple pathways to autoimmunity. Nat Immunol. 2017;18(7):716&#x2010;724. 10.1038/ni.3731</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3731</ArticleId><ArticleId IdType="pmc">PMC5791156</ArticleId><ArticleId IdType="pubmed">28632714</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert LJ, Inman RD. Molecular mimicry and autoimmunity. N. Engl J Med. 1999;341(27):2068&#x2010;2074. 10.1056/nejm199912303412707</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejm199912303412707</ArticleId><ArticleId IdType="pubmed">10615080</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M, Restrepo&#x2010;Jim&#xe9;nez P, Monsalve DM, et&#xa0;al. Molecular mimicry and autoimmunity. J Autoimmun. 2018;95:100&#x2010;123. 10.1016/j.jaut.2018.10.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.10.012</ArticleId><ArticleId IdType="pubmed">30509385</ArticleId></ArticleIdList></Reference><Reference><Citation>Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. 2019;11(8):762. 10.3390/v11080762</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11080762</ArticleId><ArticleId IdType="pmc">PMC6723519</ArticleId><ArticleId IdType="pubmed">31430946</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco Y, Acosta&#x2010;Ampudia Y, Monsalve DM, Chang C, Gershwin ME, Anaya JM. Bystander activation and autoimmunity. J Autoimmun. 2019;103:102301. 10.1016/j.jaut.2019.06.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.06.012</ArticleId><ArticleId IdType="pubmed">31326230</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, et&#xa0;al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497&#x2010;506. 10.1016/s0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Damoiseaux J, Dotan A, Fritzler MJ, et&#xa0;al. Autoantibodies and SARS&#x2010;CoV2 infection: the spectrum from association to clinical implication: report of the 15th Dresden Symposium on Autoantibodies. Autoimmun Rev. 2022;21(3):103012. 10.1016/j.autrev.2021.103012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.103012</ArticleId><ArticleId IdType="pmc">PMC8656211</ArticleId><ArticleId IdType="pubmed">34896650</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post&#x2010;acute sequelae of COVID&#x2010;19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021;12:698169. 10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, et&#xa0;al. Diverse functional autoantibodies in patients with COVID&#x2010;19. Nature. 2021;595(7866):283&#x2010;288. 10.1038/s41586-021-03631-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SE, Feng A, Meng W, et&#xa0;al. New&#x2010;onset IgG autoantibodies in hospitalized patients with COVID&#x2010;19. Nat Commun. 2021;12(1):5417. 10.1038/s41467-021-25509-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25509-3</ArticleId><ArticleId IdType="pmc">PMC8440763</ArticleId><ArticleId IdType="pubmed">34521836</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AKH, Woodhouse I, Schneider F, Kulpa DA, Silvestri G, Maier CL. Broad auto&#x2010;reactive IgM responses are common in critically ill patients, including those with COVID&#x2010;19. Cell Rep Med. 2021;2(6):100321. 10.1016/j.xcrm.2021.100321</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100321</ArticleId><ArticleId IdType="pmc">PMC8160082</ArticleId><ArticleId IdType="pubmed">34075365</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenfeld M, Tincani A, Andreoli L, et&#xa0;al. Covid&#x2010;19 and autoimmunity. Autoimmun Rev. 2020;19(8):102597. 10.1016/j.autrev.2020.102597</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102597</ArticleId><ArticleId IdType="pmc">PMC7289100</ArticleId><ArticleId IdType="pubmed">32535093</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff MC, Ramonell RP, Nguyen DC, et&#xa0;al. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID&#x2010;19. Nat Immunol. 2020;21(12):1506&#x2010;1516. 10.1038/s41590-020-00814-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00814-z</ArticleId><ArticleId IdType="pmc">PMC7739702</ArticleId><ArticleId IdType="pubmed">33028979</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS&#x2010;CoV&#x2010;2 spike glycoprotein. Cell. 2020;181(2):281&#x2010;292. e6. 10.1016/j.cell.2020.11.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.11.032</ArticleId><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et&#xa0;al. Multiple early factors anticipate post&#x2010;acute COVID&#x2010;19 sequelae. Cell. 2022;185(5):881&#x2010;895. e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight JS, Caricchio R, Casanova JL, et&#xa0;al. The intersection of COVID&#x2010;19 and autoimmunity. J Clin Invest. 2021;131(24). 10.1172/jci154886</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci154886</ArticleId><ArticleId IdType="pmc">PMC8670833</ArticleId><ArticleId IdType="pubmed">34710063</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitlin AD, Mayer CT, Oliveira TY, et&#xa0;al. HUMORAL IMMUNITY. T cell help controls the speed of the cell cycle in germinal center B cells. Science. 2015;349(6248):643&#x2010;646. 10.1126/science.aac4919</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aac4919</ArticleId><ArticleId IdType="pmc">PMC4809261</ArticleId><ArticleId IdType="pubmed">26184917</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko N, Kuo HH, Boucau J, et&#xa0;al. Loss of Bcl&#x2010;6&#x2010;expressing T follicular helper cells and germinal centers in COVID&#x2010;19. Cell. 2020;183(1):143&#x2010;157. e13. 10.1016/j.cell.2020.08.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.025</ArticleId><ArticleId IdType="pmc">PMC7437499</ArticleId><ArticleId IdType="pubmed">32877699</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenks SA, Cashman KS, Zumaquero E, et&#xa0;al. Distinct effector B cells induced by unregulated toll&#x2010;like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity. 2018;49(4):725&#x2010;739. e6. 10.1016/j.immuni.2018.08.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.08.015</ArticleId><ArticleId IdType="pmc">PMC6217820</ArticleId><ArticleId IdType="pubmed">30314758</ArticleId></ArticleIdList></Reference><Reference><Citation>Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7&#x2010;mediated recognition of single&#x2010;stranded RNA. Science. 2004;303(5663):1529&#x2010;1531. 10.1126/science.1093616</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1093616</ArticleId><ArticleId IdType="pubmed">14976261</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown GJ, Ca&#xf1;ete PF, Wang H, et&#xa0;al. TLR7 gain&#x2010;of&#x2010;function genetic variation causes human lupus. Nature. 2022;605(7909):349&#x2010;356. 10.1038/s41586-022-04642-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04642-z</ArticleId><ArticleId IdType="pmc">PMC9095492</ArticleId><ArticleId IdType="pubmed">35477763</ArticleId></ArticleIdList></Reference><Reference><Citation>Petes C, Odoardi N, Gee K. The toll for trafficking: toll&#x2010;like receptor 7 delivery to the endosome. Front Immunol. 2017;8:1075. 10.3389/fimmu.2017.01075</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01075</ArticleId><ArticleId IdType="pmc">PMC5591332</ArticleId><ArticleId IdType="pubmed">28928743</ArticleId></ArticleIdList></Reference><Reference><Citation>Fillatreau S, Manfroi B, D&#xf6;rner T. Toll&#x2010;like receptor signalling in B cells during systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(2):98&#x2010;108. 10.1038/s41584-020-00544-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-00544-4</ArticleId><ArticleId IdType="pmc">PMC7747191</ArticleId><ArticleId IdType="pubmed">33339987</ArticleId></ArticleIdList></Reference><Reference><Citation>Asano T, Boisson B, Onodi F, et&#xa0;al. X&#x2010;linked recessive TLR7 deficiency in &#x223c;1% of men under 60 years old with life&#x2010;threatening COVID&#x2010;19. Science immunology. 2021;6(62).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8532080</ArticleId><ArticleId IdType="pubmed">34413140</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S, Wang C, Mao X, Hao Y. B cell dysfunction associated with aging and autoimmune diseases. Front Immunol. 2019;10:318. 10.3389/fimmu.2019.00318</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00318</ArticleId><ArticleId IdType="pmc">PMC6400972</ArticleId><ArticleId IdType="pubmed">30873171</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellegounder D, Zafari P, Rajabinejad M, Taghadosi M, Kapahi P. Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age&#x2010;dependent COVID&#x2010;19 morbidity and mortality. A review and hypothesis. Int Immunopharm. 2021;98:107806. 10.1016/j.intimp.2021.107806</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107806</ArticleId><ArticleId IdType="pmc">PMC8141786</ArticleId><ArticleId IdType="pubmed">34352471</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinkmann V, Reichard U, Goosmann C, et&#xa0;al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532&#x2010;1535. 10.1126/science.1092385</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1092385</ArticleId><ArticleId IdType="pubmed">15001782</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Kaplan MJ. The role of neutrophils and NETosis in autoimmune and renal diseases. Nat Rev Nephrol. 2016;12(7):402&#x2010;413. 10.1038/nrneph.2016.71</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2016.71</ArticleId><ArticleId IdType="pmc">PMC5510606</ArticleId><ArticleId IdType="pubmed">27241241</ArticleId></ArticleIdList></Reference><Reference><Citation>Khandpur R, Carmona&#x2010;Rivera C, Vivekanandan&#x2010;Giri A, et&#xa0;al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med. 2013;5(178): 178ra40. 10.1126/scitranslmed.3005580</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3005580</ArticleId><ArticleId IdType="pmc">PMC3727661</ArticleId><ArticleId IdType="pubmed">23536012</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillot C, Favresse J, Mullier F, Lecompte T, Dogn&#xe9; JM, Douxfils J. NETosis and the immune system in COVID&#x2010;19: mechanisms and potential treatments. Front Pharmacol. 2021;12:708302. 10.3389/fphar.2021.708302</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.708302</ArticleId><ArticleId IdType="pmc">PMC8376580</ArticleId><ArticleId IdType="pubmed">34421600</ArticleId></ArticleIdList></Reference><Reference><Citation>Arcanjo A, Logullo J, Menezes CCB, et&#xa0;al. The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID&#x2010;19). Sci Rep. 2020;10(1):19630. 10.1038/s41598-020-76781-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-76781-0</ArticleId><ArticleId IdType="pmc">PMC7665044</ArticleId><ArticleId IdType="pubmed">33184506</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Yalavarthi S, Navaz SA, et&#xa0;al. Autoantibodies stabilize neutrophil extracellular traps in COVID&#x2010;19. JCI insight. 2021;6(15). 10.1172/jci.insight.150111</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.150111</ArticleId><ArticleId IdType="pmc">PMC8410057</ArticleId><ArticleId IdType="pubmed">34166229</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Estes SK, Ali RA, et&#xa0;al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID&#x2010;19. Sci Transl Med. 2020;12(570). 10.1126/scitranslmed.abd3876</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd3876</ArticleId><ArticleId IdType="pmc">PMC7724273</ArticleId><ArticleId IdType="pubmed">33139519</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et&#xa0;al. Post&#x2010;acute COVID&#x2010;19 syndrome. Nat Med. 2021;27(4):601&#x2010;615. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, et&#xa0;al. Autoantibodies against type I IFNs in patients with life&#x2010;threatening COVID&#x2010;19. Science. 2020;370(6515).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber CN, Patel RS, Trachtman R, et&#xa0;al. Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS&#x2010;C). Cell. 2020;183(4):982&#x2010;995. e14. 10.1016/j.cell.2020.09.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.034</ArticleId><ArticleId IdType="pmc">PMC7489877</ArticleId><ArticleId IdType="pubmed">32991843</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Ebinger JE, Mostafa R, et&#xa0;al. Paradoxical sex&#x2010;specific patterns of autoantibody response to SARS&#x2010;CoV&#x2010;2 infection. J Transl Med. 2021;19(1):524. 10.1186/s12967-021-03184-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03184-8</ArticleId><ArticleId IdType="pmc">PMC8716184</ArticleId><ArticleId IdType="pubmed">34965855</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehbe Z, Hammoud SH, Yassine HM, Fardoun M, El&#x2010;Yazbi AF, Eid AH. Molecular and biological mechanisms underlying gender differences in COVID&#x2010;19 severity and mortality. Front Immunol. 2021;12:659339. 10.3389/fimmu.2021.659339</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.659339</ArticleId><ArticleId IdType="pmc">PMC8138433</ArticleId><ArticleId IdType="pubmed">34025658</ArticleId></ArticleIdList></Reference><Reference><Citation>Scofield RH. Autoantibodies as predictors of disease. Lancet. 2004;363(9420):1544&#x2010;1546. 10.1016/s0140-6736(04)16154-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(04)16154-0</ArticleId><ArticleId IdType="pubmed">15135604</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceribelli A, Fredi M, Taraborelli M, et&#xa0;al. Anti&#x2010;MJ/NXP&#x2010;2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. Arthritis Res Ther. 2012;14(2):R97. 10.1186/ar3822</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3822</ArticleId><ArticleId IdType="pmc">PMC3446471</ArticleId><ArticleId IdType="pubmed">22546500</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang EH, Ha YJ, Lee YJ. Autoantibody biomarkers in rheumatic diseases. Int J Mol Sci. 2020;21(4):1382. 10.3390/ijms21041382</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21041382</ArticleId><ArticleId IdType="pmc">PMC7073052</ArticleId><ArticleId IdType="pubmed">32085664</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlachoyiannopoulos PG, Magira E, Alexopoulos H, et&#xa0;al. Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID&#x2010;19. Ann Rheum Dis. 2020;79(12):1661&#x2010;1663. 10.1136/annrheumdis-2020-218009</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218009</ArticleId><ArticleId IdType="pubmed">32581086</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Han T, Chen J, et&#xa0;al. Clinical and autoimmune characteristics of severe and critical cases of COVID&#x2010;19. Clinical and translational science. 2020;13(6):1077&#x2010;1086. 10.1111/cts.12805</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.12805</ArticleId><ArticleId IdType="pmc">PMC7264560</ArticleId><ArticleId IdType="pubmed">32315487</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossuyt X, De Langhe E, Borghi MO, Meroni PL. Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases. Nat Rev Rheumatol. 2020;16(12):715&#x2010;726. 10.1038/s41584-020-00522-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-00522-w</ArticleId><ArticleId IdType="pubmed">33154583</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll&#x2010;like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity. 2006;25(3):417&#x2010;428. 10.1016/j.immuni.2006.07.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2006.07.013</ArticleId><ArticleId IdType="pubmed">16973389</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanmohammadi S, Rezaei N. Role of Toll&#x2010;like receptors in the pathogenesis of COVID&#x2010;19. J Med Virol. 2021;93(5):2735&#x2010;2739. 10.1002/jmv.26826</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26826</ArticleId><ArticleId IdType="pmc">PMC8014260</ArticleId><ArticleId IdType="pubmed">33506952</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa TJ, Potje SR, Fraga&#x2010;Silva TFC, et&#xa0;al. Mitochondrial DNA and TLR9 activation contribute to SARS&#x2010;CoV&#x2010;2&#x2010;induced endothelial cell damage. Vasc Pharmacol. 2022;142:106946. 10.1016/j.vph.2021.106946</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2021.106946</ArticleId><ArticleId IdType="pmc">PMC8612754</ArticleId><ArticleId IdType="pubmed">34838735</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezemer GFG, Garssen J. TLR9 and COVID&#x2010;19: a multidisciplinary theory of a multifaceted therapeutic target. Front Pharmacol. 2020;11:601685. 10.3389/fphar.2020.601685</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.601685</ArticleId><ArticleId IdType="pmc">PMC7844586</ArticleId><ArticleId IdType="pubmed">33519463</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J, Avalos AM, Mao SY, et&#xa0;al. Toll&#x2010;like receptor 9&#x2010;dependent activation by DNA&#x2010;containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol. 2007;8(5):487&#x2010;496. 10.1038/ni1457</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1457</ArticleId><ArticleId IdType="pubmed">17417641</ArticleId></ArticleIdList></Reference><Reference><Citation>Arunachalam PS, Wimmers F, Mok CKP, et&#xa0;al. Systems biological assessment of immunity to mild versus severe COVID&#x2010;19 infection in humans. Science. 2020;369(6508):1210&#x2010;1220. 10.1126/science.abc6261</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6261</ArticleId><ArticleId IdType="pmc">PMC7665312</ArticleId><ArticleId IdType="pubmed">32788292</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Long X, Xu Q, et&#xa0;al. Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID&#x2010;19 patients. Cell Mol Immunol. 2020;17(9):992&#x2010;994. 10.1038/s41423-020-0492-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0492-x</ArticleId><ArticleId IdType="pmc">PMC7332851</ArticleId><ArticleId IdType="pubmed">32620787</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciascia S, Amigo MC, Roccatello D, Khamashta M. Diagnosing antiphospholipid syndrome: &#x2018;extra&#x2010;criteria&#x2019; manifestations and technical advances. Nat Rev Rheumatol. 2017;13(9):548&#x2010;560. 10.1038/nrrheum.2017.124</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2017.124</ArticleId><ArticleId IdType="pubmed">28769114</ArticleId></ArticleIdList></Reference><Reference><Citation>Asherson RA, Cervera R. Antiphospholipid antibodies and infections. Ann Rheum Dis. 2003;62(5):388&#x2010;393. 10.1136/ard.62.5.388</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.62.5.388</ArticleId><ArticleId IdType="pmc">PMC1754545</ArticleId><ArticleId IdType="pubmed">12695147</ArticleId></ArticleIdList></Reference><Reference><Citation>Tangye SG, Al&#x2010;Herz W, Bousfiha A, et&#xa0;al. Human inborn errors of immunity: 2019 update on the classification from the international union of immunological Societies expert committee. J Clin Immunol. 2020;40(1):24&#x2010;64. 10.1007/s10875-019-00737-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-019-00737-x</ArticleId><ArticleId IdType="pmc">PMC7082301</ArticleId><ArticleId IdType="pubmed">31953710</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkel PA, Lebo T, Knight V. Functional analysis of anti&#x2010;cytokine autoantibodies using flow cytometry. Front Immunol. 2019;10:1517. 10.3389/fimmu.2019.01517</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01517</ArticleId><ArticleId IdType="pmc">PMC6640114</ArticleId><ArticleId IdType="pubmed">31354706</ArticleId></ArticleIdList></Reference><Reference><Citation>Frede N, Glocker EO, Wanders J, et&#xa0;al. Evidence for non&#x2010;neutralizing autoantibodies against IL&#x2010;10 signalling components in patients with inflammatory bowel disease. BMC Immunol. 2014;15(1):10. 10.1186/1471-2172-15-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2172-15-10</ArticleId><ArticleId IdType="pmc">PMC3942769</ArticleId><ArticleId IdType="pubmed">24581234</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccoli L, Campo I, Fregni CS, et&#xa0;al. Neutralization and clearance of GM&#x2010;CSF by autoantibodies in pulmonary alveolar proteinosis. Nat Commun. 2015;6(1):7375. 10.1038/ncomms8375</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8375</ArticleId><ArticleId IdType="pmc">PMC4477037</ArticleId><ArticleId IdType="pubmed">26077231</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen TC, Fudala R, Nash SE, Kurdowska A. Anti&#x2010;interleukin 8 autoantibody: interleukin 8 immune complexes visualized by laser confocal microscopy in injured lung. Archives Pathology Laboratory Med. 2007;131(3):452&#x2010;456. 10.5858/2007-131-452-aaicvb</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/2007-131-452-aaicvb</ArticleId><ArticleId IdType="pubmed">17516748</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappellano G, Orilieri E, Woldetsadik AD, et&#xa0;al. Anti&#x2010;cytokine autoantibodies in autoimmune diseases. Am J Clin Exp Immunol. 2012;1(2):136&#x2010;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3714194</ArticleId><ArticleId IdType="pubmed">23885320</ArticleId></ArticleIdList></Reference><Reference><Citation>von Stemann JH, Rigas AS, Th&#xf8;rner LW, et&#xa0;al. Prevalence and correlation of cytokine&#x2010;specific autoantibodies with epidemiological factors and C&#x2010;reactive protein in 8,972 healthy individuals: results from the Danish Blood Donor Study. PloS one. 2017;12(6):e0179981. 10.1371/journal.pone.0179981</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0179981</ArticleId><ArticleId IdType="pmc">PMC5493339</ArticleId><ArticleId IdType="pubmed">28665954</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Gervais A, Le Voyer T, et&#xa0;al. Autoantibodies neutralizing type I IFNs are present in &#x223c;4% of uninfected individuals over 70 years old and account for &#x223c;20% of COVID&#x2010;19 deaths. Science Immunology. 2021;6(62).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8521484</ArticleId><ArticleId IdType="pubmed">34413139</ArticleId></ArticleIdList></Reference><Reference><Citation>Burbelo PD, Seam N, Groot S, et&#xa0;al. Rapid induction of autoantibodies during ARDS and septic shock. J Transl Med. 2010;8(1):97. 10.1186/1479-5876-8-97</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-8-97</ArticleId><ArticleId IdType="pmc">PMC2970592</ArticleId><ArticleId IdType="pubmed">20946647</ArticleId></ArticleIdList></Reference><Reference><Citation>Juanes&#x2010;Velasco P, Landeira&#x2010;Vi&#xf1;uela A, Garc&#xed;a&#x2010;Vaquero ML, et&#xa0;al. SARS&#x2010;CoV&#x2010;2 infection triggers auto&#x2010;immune response in ARDS. Front Immunol. 2022;13:732197. 10.3389/fimmu.2022.732197</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.732197</ArticleId><ArticleId IdType="pmc">PMC8831226</ArticleId><ArticleId IdType="pubmed">35154090</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio CR, Cotugno N, Sardh F, et&#xa0;al. The immunology of multisystem inflammatory syndrome in children with COVID&#x2010;19. Cell. 2020;183(4):968&#x2010;981.e7. 10.1016/j.cell.2020.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7474869</ArticleId><ArticleId IdType="pubmed">32966765</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufort EM, Koumans EH, Chow EJ, et&#xa0;al. Multisystem inflammatory syndrome in children in New York state. N. Engl J Med. 2020;383(4):347&#x2010;358. 10.1056/nejmoa2021756</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2021756</ArticleId><ArticleId IdType="pmc">PMC7346766</ArticleId><ArticleId IdType="pubmed">32598830</ArticleId></ArticleIdList></Reference><Reference><Citation>ten Dijke P, Goumans MJ, Pardali E. Endoglin in angiogenesis and vascular diseases. Angiogenesis. 2008;11(1):79&#x2010;89. 10.1007/s10456-008-9101-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-008-9101-9</ArticleId><ArticleId IdType="pubmed">18283546</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeifer J, Thurner B, Kessel C, et&#xa0;al. Autoantibodies against interleukin&#x2010;1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study. Lancet Rheumatology. 2022;4(5):e329&#x2010;e337. 10.1016/s2665-9913(22)00064-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2665-9913(22)00064-9</ArticleId><ArticleId IdType="pmc">PMC8963770</ArticleId><ArticleId IdType="pubmed">35368387</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long&#x2010;haul COVID. Nat Immunol. 2022;23(2):194&#x2010;202. 10.1038/s41590-021-01104-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al&#x2010;Aly Z. Long&#x2010;term cardiovascular outcomes of COVID&#x2010;19. Nat Med. 2022;28(3):583&#x2010;590. 10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P, Casari G, Townsend L, et&#xa0;al. Studying severe long COVID to understand post&#x2010;infectious disorders beyond COVID&#x2010;19. Nat Med. 2022;28(5):879&#x2010;882. 10.1038/s41591-022-01766-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01766-7</ArticleId><ArticleId IdType="pubmed">35383311</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Zlitni S, Brooks EF, et&#xa0;al. Gastrointestinal symptoms and fecal shedding of SARS&#x2010;CoV&#x2010;2 RNA suggest prolonged gastrointestinal infection. Med. 2022;3(6):371&#x2010;387.e9. 10.1016/j.medj.2022.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Braddom AE, Batugedara G, Bol S, Bunnik EM. Potential functions of atypical memory B cells in Plasmodium&#x2010;exposed individuals. Int J Parasitol. 2020;50(13):1033&#x2010;1042. 10.1016/j.ijpara.2020.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijpara.2020.08.003</ArticleId><ArticleId IdType="pmc">PMC7666103</ArticleId><ArticleId IdType="pubmed">32987039</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliviero B, Varchetta S, Mele D, et&#xa0;al. Expansion of atypical memory B cells is a prominent feature of COVID&#x2010;19. Cell Mol Immunol. 2020;17(10):1101&#x2010;1103. 10.1038/s41423-020-00542-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00542-2</ArticleId><ArticleId IdType="pmc">PMC7463104</ArticleId><ArticleId IdType="pubmed">32879471</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehser J, Holdener M, Christen S, et&#xa0;al. Molecular mimicry rather than identity breaks T&#x2010;cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis. J Autoimmun. 2013;42:39&#x2010;49. 10.1016/j.jaut.2012.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2012.11.001</ArticleId><ArticleId IdType="pubmed">23200317</ArticleId></ArticleIdList></Reference><Reference><Citation>Holdener M, Hintermann E, Bayer M, et&#xa0;al. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med. 2008;205(6):1409&#x2010;1422. 10.1084/jem.20071859</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20071859</ArticleId><ArticleId IdType="pmc">PMC2413037</ArticleId><ArticleId IdType="pubmed">18474629</ArticleId></ArticleIdList></Reference><Reference><Citation>Benvenga S, Guarneri F. Molecular mimicry and autoimmune thyroid disease. Rev Endocr Metab Disord. 2016;17(4):485&#x2010;498. 10.1007/s11154-016-9363-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-016-9363-2</ArticleId><ArticleId IdType="pubmed">27307072</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolcino M, Puccetti A, Barbieri A, et&#xa0;al. Infections and autoimmunity: role of human cytomegalovirus in autoimmune endothelial cell damage. Lupus. 2015;24(4&#x2010;5):419&#x2010;432. 10.1177/0961203314558677</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314558677</ArticleId><ArticleId IdType="pubmed">25801885</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez Y, Rojas M, Pacheco Y, et&#xa0;al. Guillain&#x2013;Barr&#xe9; syndrome, transverse myelitis and infectious diseases. Cell Mol Immunol. 2018;15(6):547&#x2010;562. 10.1038/cmi.2017.142</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2017.142</ArticleId><ArticleId IdType="pmc">PMC6079071</ArticleId><ArticleId IdType="pubmed">29375121</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulamhusein AF, Hirschfield GM. Primary biliary cholangitis: pathogenesis and therapeutic opportunities. Nat Rev Gastroenterol Hepatol. 2020;17(2):93&#x2010;110. 10.1038/s41575-019-0226-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-019-0226-7</ArticleId><ArticleId IdType="pubmed">31819247</ArticleId></ArticleIdList></Reference><Reference><Citation>Quaglia M, Merlotti G, De Andrea M, Borgogna C, Cantaluppi V. Viral infections and systemic lupus erythematosus: new players in an old story. Viruses. 2021;13(2):277. 10.3390/v13020277</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020277</ArticleId><ArticleId IdType="pmc">PMC7916951</ArticleId><ArticleId IdType="pubmed">33670195</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiemstra HS, Schloot NC, van Veelen PA, et&#xa0;al. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci USA. 2001;98(7):3988&#x2010;3991. 10.1073/pnas.071050898</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.071050898</ArticleId><ArticleId IdType="pmc">PMC31166</ArticleId><ArticleId IdType="pubmed">11274421</ArticleId></ArticleIdList></Reference><Reference><Citation>Dittfeld A, Gwizdek K, Michalski M, Wojnicz R. A possible link between the Epstein&#x2010;Barr virus infection and autoimmune thyroid disorders. Cent Eur J Immunol. 2016;41(3):297&#x2010;301. 10.5114/ceji.2016.63130</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/ceji.2016.63130</ArticleId><ArticleId IdType="pmc">PMC5099387</ArticleId><ArticleId IdType="pubmed">27833448</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata K, Kumata K, Nakayama Y, et&#xa0;al. Epstein&#x2010;barr virus lytic reactivation activates B cells polyclonally and induces activation&#x2010;induced cytidine deaminase expression: a mechanism underlying autoimmunity and its contribution to graves' disease. Viral Immunol. 2017;30(3):240&#x2010;249. 10.1089/vim.2016.0179</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2016.0179</ArticleId><ArticleId IdType="pmc">PMC5393416</ArticleId><ArticleId IdType="pubmed">28333576</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan Y, Jakimovski D, Ramanathan M, Weinstock&#x2010;Guttman B, Zivadinov R. The role of Epstein&#x2010;Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging. Neural Regen Res. 2019;14(3):373&#x2010;386. 10.4103/1673-5374.245462</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.245462</ArticleId><ArticleId IdType="pmc">PMC6334604</ArticleId><ArticleId IdType="pubmed">30539801</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Chu A. Sj&#xf6;gren&#x2019;s syndrome and viral infections. Rheumatology Ther. 2021;8(3):1051&#x2010;1059. 10.1007/s40744-021-00334-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40744-021-00334-8</ArticleId><ArticleId IdType="pmc">PMC8380615</ArticleId><ArticleId IdType="pubmed">34227038</ArticleId></ArticleIdList></Reference><Reference><Citation>Maya R, Gershwin ME, Shoenfeld Y. Hepatitis B virus (HBV) and autoimmune disease. Clin Rev Allergy Immunol. 2008;34(1):85&#x2010;102. 10.1007/s12016-007-8013-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-007-8013-6</ArticleId><ArticleId IdType="pubmed">18270862</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri C, Colaci M, Fallahi P, Ferrari SM, Antonelli A, Giuggioli D. Thyroid involvement in hepatitis C virus&#x2010;infected patients with/without mixed cryoglobulinemia. Front Endocrinol. 2017;8:159. 10.3389/fendo.2017.00159</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2017.00159</ArticleId><ArticleId IdType="pmc">PMC5500622</ArticleId><ArticleId IdType="pubmed">28736547</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogishi M, Yotsuyanagi H, Moriya K, Koike K. Delineation of autoantibody repertoire through differential proteogenomics in hepatitis C virus&#x2010;induced cryoglobulinemia. Sci Rep. 2016;6(1):29532. 10.1038/srep29532</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep29532</ArticleId><ArticleId IdType="pmc">PMC4941579</ArticleId><ArticleId IdType="pubmed">27403724</ArticleId></ArticleIdList></Reference><Reference><Citation>Segal Y, Calabr&#xf2; M, Kanduc D, Shoenfeld Y. Human papilloma virus and lupus: the virus, the vaccine and the disease. Curr Opin Rheumatol. 2017;29(4):331&#x2010;342. 10.1097/bor.0000000000000398</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/bor.0000000000000398</ArticleId><ArticleId IdType="pubmed">28394823</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr JR. The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease. J Clin Pathol. 2016;69(4):279&#x2010;291. 10.1136/jclinpath-2015-203455</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jclinpath-2015-203455</ArticleId><ArticleId IdType="pubmed">26644521</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro FM, Gomez VE, Albuquerque EM, Klumb EM, Shoenfeld Y. Lupus and leprosy: beyond the coincidence. Immunol Res. 2015;61(1&#x2010;2):160&#x2010;163. 10.1007/s12026-014-8596-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-014-8596-y</ArticleId><ArticleId IdType="pubmed">25412733</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez&#x2010;Rial J, Rivero&#x2010;Calle I, Salas A, Martin&#xf3;n&#x2010;Torres F. Rotavirus and autoimmunity. J Infect. 2020;81(2):183&#x2010;189. 10.1016/j.jinf.2020.04.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.04.041</ArticleId><ArticleId IdType="pubmed">32360880</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucchese G, Kanduc D. Zika virus and autoimmunity: from microcephaly to Guillain&#x2010;Barr&#xe9; syndrome, and beyond. Autoimmun Rev. 2016;15(8):801&#x2010;808. 10.1016/j.autrev.2016.03.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2016.03.020</ArticleId><ArticleId IdType="pubmed">27019049</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>